title: Signal transduction blockade and cancer: combination therapy or multi-targeted inhibitors?
authors.forename: D J
authors.initials: DJ
authors.lastname: Kerr
authors.forename: N B
authors.initials: NB
authors.lastname: La Thangue
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D004791:Enzyme Inhibitors; D047428:Protein Kinase Inhibitors